Company
Convatec
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
20
510(k), De Novo and PMA
Device trials
41
As lead sponsor, any status
Adverse event reports
7,457
Received Nov 1, 2025 to Nov 19, 2026
Recall records
72
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Convatec, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Convatec.
Latest FDA decisions
The 8 newest of 20 since 2015.
K260737 · Decided Aug 5, 2026 · 152 days after receipt
Device type: Catheter, Straight (EZD) · GI, Urology & Nephrology
K253263 · Decided Jun 24, 2026 · 268 days after receipt
Device type: Negative Pressure Wound Therapy Powered Suction Pump (OMP) · General & Plastic Surgery
K252943 · Decided Apr 1, 2026 · 198 days after receipt
Device type: Catheter, Straight (EZD) · GI, Urology & Nephrology
17 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- EDX110 Randomized Control Trial for Treatment of DFUsPivotal-lookingActive, not recruiting
NCT07209358 · 300 participants · Start Oct 30, 2025 · Primary completion Mar 31, 2027
Device: EDX110 · For: Wound Heal; Diabetic Foot Ulcer
Sites: Phoenix, Arizona; Los Angeles, California; Santa Ana, California · 10 sites in all
- Efficacy and Safety of a Nitric Oxide Generating Dressing for Diabetic Foot Ulcers (ONWARD)Recruiting
NCT07438951 · 102 participants (planned) · Start Sep 1, 2026 · Primary completion Sep 2027
Device: ConvaNiox · For: Diabetic Foot Ulcers (DFUs)
Sites: Ashton-under-Lyne, United Kingdom
- IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot UlcersPivotal-lookingActive, not recruiting
NCT06616844 · 235 participants (planned) · Start Feb 12, 2025 · Primary completion Mar 2027
Device: InnovaMatrix® AC · For: Wound Heal; Ulcer
Sites: Fresno, California; Los Angeles, California; San Diego, California · 21 sites in all
38 more trials with a free account
Reports received
7,457
Received Nov 1, 2025 to Nov 19, 2026. Includes 2 of another or unstated type.
Malfunction reports
7,402
99% of reports
Injury reports
53
0.7% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 90 | 1 | 0 | 0 |
| Jan 24 | 64 | 5 | 0 | 0 |
| Feb 24 | 193 | 4 | 0 | 0 |
| Mar 24 | 239 | 2 | 0 | 0 |
| Apr 24 | 89 | 3 | 0 | 0 |
| May 24 | 54 | 5 | 0 | 0 |
| Jun 24 | 102 | 2 | 0 | 0 |
| Jul 24 | 262 | 3 | 0 | 0 |
| Aug 24 | 305 | 9 | 0 | 0 |
| Sep 24 | 532 | 1 | 0 | 0 |
| Oct 24 | 297 | 15 | 0 | 0 |
| Nov 24 | 81 | 2 | 0 | 0 |
| Dec 24 | 107 | 2 | 0 | 0 |
| Jan 25 | 468 | 7 | 0 | 0 |
| Feb 25 | 564 | 9 | 0 | 0 |
| Mar 25 | 119 | 4 | 0 | 0 |
| Apr 25 | 325 | 2 | 0 | 0 |
| May 25 | 269 | 6 | 1 | 0 |
| Jun 25 | 185 | 9 | 0 | 0 |
| Jul 25 | 91 | 5 | 0 | 0 |
| Aug 25 | 101 | 5 | 0 | 0 |
| Sep 25 | 376 | 7 | 0 | 0 |
| Oct 25 | 126 | 16 | 0 | 0 |
| Nov 25 | 386 | 5 | 0 | 0 |
| Dec 25 | 219 | 7 | 0 | 0 |
| Jan 26 | 316 | 12 | 0 | 0 |
| Feb 26 | 147 | 7 | 0 | 0 |
| Mar 26 | 105 | 1 | 0 | 0 |
| Apr 26 | 244 | 5 | 0 | 0 |
| May 26 | 183 | 1 | 0 | 0 |
| Jun 26 | 127 | 3 | 0 | 0 |
| Jul 26 | 881 | 4 | 0 | 0 |
| Aug 26 | 3,192 | 1 | 0 | 2 |
| Sep 26 | 1,467 | 3 | 0 | 0 |
| Oct 26 | 135 | 4 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
7 more in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2986-2026 · Started Jul 6, 2026 · Posted by FDA Aug 19, 2026
Reason given: Urostomy Pouches may leak from cap during use.
Cause as FDA categorized it: Material/Component Contamination · Device type: Bag, Urine Collecting, Ureterostomy (EXG)
Z-2677-2026 · Started Jun 8, 2026 · Posted by FDA Jul 7, 2026
Reason given: Surgical dressing manufactured out of specification (greater thickness).
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Dressing, Wound, Drug (FRO)
- Convatec, EsteemBody Drainable Pouch REF:423643, 10-45mmOpen, Classified
Z-1582-2026 · Started Feb 16, 2026 · Posted by FDA Mar 19, 2026
Reason given: Drainable large pouch may leak due to manufacturing issue.
Cause as FDA categorized it: Process control · Device type: Bag, Drainage, With Adhesive, Ostomy (FON)
69 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.